24886-52-0
Chemical Structure
Azaphen free base
Synonym(s): Azafen free base; Pipofezin; Pipofezine
- CAS No.: 24886-52-0
- Formula:C16H19N5O
- Molecular Weight:297.35
IUPAC Name: 5-methyl-3-(4-methylpiperazin-1-yl)-5H-benzo[b]pyridazino[4,3-e][1,4]oxazine
InChIKey: SDYYIRPAZHJOLM-UHFFFAOYSA-N
SMILES: CN1C2=C(C=CC=C2)OC3=NN=C(N4CCN(CC4)C)C=C31
Biological Activity: Azaphen free base (Azafen free base) is an orally active tricyclic antidepressant that inhibits the reuptake of serotonin and monoamines, regulates the 5-HT2c receptor, and exerts sedative, antidepressant and anxiolytic effects. Azaphen free base increases the bioavailability of serotonin in the synaptic cleft, does not block muscarinic receptors or affect monoamine oxidase activity, and binds to the human serotonin transporter via salt bridges, π-stacking, π-cation and hydrophobic interactions. Azaphen free base can be used in studies related to depression[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Azaphen free base | Azaphen free base (Azafen free base) is an orally active tricyclic antidepressant that inhibits the reuptake of serotonin and monoamines, regulates the 5-HT2c receptor, and exerts sedative, antidepressant and anxiolytic effects. Azaphen free base increases the bioavailability of serotonin in the synaptic cleft, does not block muscarinic receptors or affect monoamine oxidase activity, and binds to the human serotonin transporter via salt bridges, π-stacking, π-cation and hydrophobic interactions. Azaphen free base can be used in studies related to depression. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
-
[1]. Imran M, et al. Study of various pyridazine and phthalazine drugs with diverse therapeutically and agrochemically activities. Russ J Bioorg Chem. 2020;46(5):745-767.
- [2]. Aleeva GN, et al. Comparison of antidepressant effects of azafan, tianeptine, and paroxetine. Bulletin of experimental biology and medicine. 2009 Jul;148(1):54-6.
- [3]. Lin J, et al. Uncovering the Elusive Structures and Mechanisms of Prevalent Antidepressants. Advanced therapeutics. 2024 Sep;7(9):2400117.